X0407 4 2023-01-11 0 0001348911 KalVista Pharmaceuticals, Inc. KALV 0001860131 Audhya Paul K. C/O KALVISTA PHARMACEUTICALS, INC. 55 CAMBRIDGE PARKWAY, SUITE 9011 CAMBRIDGE MA 02142 0 1 0 0 Chief Medical Officer 0 Common Stock 2023-05-17 4 M 0 6447 A 15794 D Common Stock 2023-05-18 4 S 0 2780 10.1444 D 13014 D Restricted Stock Unit 2023-01-11 4 A 0 48334 0.00 A Common Stock 48334 48334 D Restricted Stock Unit 2023-05-17 4 M 0 4028 0.00 D Common Stock 4028 40279 D Restricted Stock Unit 2023-05-17 4 M 0 2419 0.00 D Common Stock 2419 29025 D Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. 1/12th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on November 17, 2022, for a period of three years, subject to continued service through each vesting date. 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 17, 2022, subject to continued service through each vesting date. /s/ Benjamin L. Palleiko, Attorney-in-Fact 2023-05-19